Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9	6	10	15	33	13
Market Cap Growth	35.38%	-36.28%	-33.74%	-54.33%	146.41%	95.65%
Enterprise Value	8	6	10	19	41	22
Last Close Price	0.30	0.21	0.33	0.50	1.10	0.45
PE Ratio	9.74	56.44	-	3.90	4.09	3.24
PS Ratio	0.17	0.13	0.20	0.27	0.52	0.25
PB Ratio	0.46	0.33	0.53	0.81	2.29	2.19
P/TBV Ratio	0.46	0.33	0.53	0.81	2.29	2.19
P/FCF Ratio	5.23	16.21	8.89	4.15	11.90	11.83
P/OCF Ratio	3.93	6.70	8.05	3.66	10.75	9.94
EV/Sales Ratio	0.15	0.13	0.20	0.35	0.64	0.42
EV/EBITDA Ratio	2.85	11.12	21.85	6.31	6.68	6.14
EV/EBIT Ratio	5.49	25.26	85.75	7.08	7.07	6.72
EV/FCF Ratio	4.57	16.26	9.22	5.39	14.84	19.48
Debt / Equity Ratio	0.07	0.09	0.14	0.11	0.42	1.84
Debt / EBITDA Ratio	0.47	1.14	1.91	0.55	0.84	2.41
Debt / FCF Ratio	0.76	4.61	2.39	0.57	2.18	9.90
Asset Turnover	2.03	1.95	2.00	2.22	2.63	2.47
Inventory Turnover	4.05	4.32	4.37	4.37	4.96	4.87
Quick Ratio	1.20	1.04	1.21	0.99	0.66	0.46
Current Ratio	3.26	2.92	3.39	3.16	1.95	1.26
Return on Equity (ROE)	4.85%	0.59%	-0.18%	23.33%	78.55%	103.22%
Return on Assets (ROA)	3.52%	0.61%	0.30%	6.77%	14.94%	9.53%
Return on Capital (ROIC)	4.32%	0.74%	0.36%	8.38%	19.26%	12.73%
Return on Capital Employed (ROCE)	7.20%	1.20%	0.60%	13.70%	35.70%	33.10%
Earnings Yield	10.21%	1.77%	-0.34%	25.64%	24.44%	30.88%
FCF Yield	19.13%	6.17%	11.25%	24.08%	8.40%	8.46%
Buyback Yield / Dilution	-4.24%	-3.08%	7.34%	-0.65%	-3.07%	-5.31%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.